Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

For the drug in­dus­try, Pres­i­dent Don­ald Trump’s tar­iffs haven’t start­ed to re­al­ly hurt. At least not yet.

On Thurs­day, sev­er­al of the world’s largest phar­ma …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER